taraxasterol has been researched along with cyclin d1 in 2 studies
| Studies (taraxasterol) | Trials (taraxasterol) | Recent Studies (post-2010) (taraxasterol) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 56 | 0 | 44 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, T; Ke, Y; Kui, X; Li, Y; Wang, L; Wang, W; Wang, Y; Xiao, C; Zhang, C; Zhou, D; Zhou, H; Zhou, Q | 1 |
| Li, J; Xin, C; Yang, J; Yin, G | 1 |
2 other study(ies) available for taraxasterol and cyclin d1
| Article | Year |
|---|---|
Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Nerve Tissue Proteins; Proto-Oncogene Proteins c-bcl-2; Sterols; Triterpenes; Xenograft Model Antitumor Assays | 2018 |
Taraxasterol suppresses the proliferation and tumor growth of androgen-independent prostate cancer cells through the FGFR2-PI3K/AKT signaling pathway.
Topics: Androgens; Animals; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Male; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptor, Fibroblast Growth Factor, Type 2; Signal Transduction | 2023 |